Thomas Taylor v. United States

550 F.2d 983, 1977 U.S. App. LEXIS 14461
CourtCourt of Appeals for the Fourth Circuit
DecidedMarch 3, 1977
Docket76-1235
StatusPublished
Cited by10 cases

This text of 550 F.2d 983 (Thomas Taylor v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Thomas Taylor v. United States, 550 F.2d 983, 1977 U.S. App. LEXIS 14461 (4th Cir. 1977).

Opinion

WINTER, Circuit Judge:

Thomas Taylor appeals from the district court’s judgment which denied him an informer’s fee of twenty-five percent of the street value of hashish seized by federal officers pursuant to a tip provided by Taylor. Taylor claims such a fee pursuant to 19 U.S.C. § 1619 (1970), as made applicable by 21 U.S.C. §§ 881(d) and (f) and 965 (1970). We affirm, but remand for further proceedings since, as we view the law, Taylor may be entitled to an informer’s fee computed on a different basis.

I.

Taylor, a merchant seaman aboard a vessel bound for the United States from Amsterdam, discovered thirty-three pounds of hashish in the back of a stereo speaker that he had agreed to list on his customs declaration for Brown, a fellow seaman. Brown had in turn agreed to transport the speaker and certain other articles for a man he had met in Amsterdam. Taylor reported the discovery to the ship’s master, who took custody of the hashish and the speaker, as well as three switchblades, another speaker, and a radio receiver, and reported the find to customs officials. When the ship docked at New Orleans, a customs officer and special agents of the Drug Enforcement Administration (DEA) boarded the vessel and seized the hashish and equipment. Under the authority of 21 U.S.C. § 886, Taylor and his fellow seaman were paid $150 for their services by DEA, but further demands for payment made to the United States Attorney, the Secretary of the Treasury and the United States Customs Office were rejected. Taylor, acting on his own behalf, filed suit seeking further recovery. The district court awarded an informer’s fee for the speakers and other goods transported equal to twenty-five percent of their value as established by a customs official, but allowed no informer’s fee for the hashish on the ground that it could not legally be valued at its street value and plaintiff offered no other evidence of value. Taylor appeals, alleging that there should have been an award of twenty-five percent of the street value of the hashish.

II.

Resolution of this case ultimately turns on the meaning of 19 U.S.C. § 1619, 1 to the extent that it is applicable. Our inquiry into the application of that provision to this case must begin with the Controlled Sub *986 stances Act. Hashish, a marihuana derivative, is a schedule I controlled substance. 21 U.S.C. § 802(15) (1970); 21 U.S.C. § 812(c) Sched. I(c)(10) (1970); and 21 C.F.R. § 1308.11(d) (1975). A schedule I substance is defined to be a drug or other substance that has a high potential for abuse, has no currently accepted medical use in treatment in the United States, and for which there is a lack of accepted safety for use under medical supervision. 21 U.S.C. § 812(b)(1). Unless the Attorney General finds the importation of such a substance to be necessary for medical, scientific, or other legitimate needs of the United States at a time when domestic sources or domestic competition are inadequate and the Administrator of the Drug Enforcement Administration issues a permit, such a substance may not be legally imported. 21 U.S.C. § 952(a) (1970); 21 C.F.R. § 1312.13 (1975).

All controlled substances are subject to forfeiture if acquired or manufactured in violation of the Act, and forfeiture will extend to other conveyances and equipment used to make or transport the substances. 21 U.S.C. § 881(a)(2), (3) and (4) (1970). If a schedule I substance is transferred, possessed, or offered for sale in violation of the Act, it is subject to summary seizure and forfeiture. 21 U.S.C. § 881(f) (1970). Section 881(d) states the law applicable to property seized under § 881:

All provisions of law relating to the seizure, summary and judicial forfeiture, and condemnation of property for violation of the customs laws; the disposition of such property or the proceeds from the sale thereof; the remission or mitigation of such forfeitures; and the compromise of claims and the award of compensation to informers in respect of such forfeitures shall apply to seizures and forfeitures incurred, or alleged to have been incurred, under the provisions of this subchapter, insofar as applicable and not inconsistent with the provisions hereof; except that such duties as are imposed upon the customs officer or any other person with respect to the seizure and forfeiture of property under the customs laws shall be performed with respect to seizures and forfeitures of property under this sub-chapter by such officers, agents, or other persons as may be authorized or designated for that purpose by the Attorney General, except to the extent that such duties arise from seizures and forfeitures effected by any customs officer.

The effect of § 881(d) was described in United States v. One Motor Yacht Named Mercury, 527 F.2d 1112, 1114 (1 Cir. 1975): “[fjorfeiture proceedings arising out of drug offenses are governed by the same statutory provisions as apply to customs forfeitures.”

Section 881(e) of Title 21 deals with property forfeited pursuant to the Act and provides that the Attorney General may retain the property for official use, may sell the property if it is not required to be destroyed by law and is not harmful to the public, may require General Services Administration to take custody of the property, or may forward it to DEA (previously the Bureau of Narcotics and Dangerous Drugs) for disposition, including delivery for medical or scientific use. Since by definition a schedule I substance is harmful, it cannot be sold nor could it be retained for use, but presumably it will be forwarded to GSA or DEA for destruction or will be turned over to agencies for research. See Newsweek, Nov. 8, 1976, at p. 53 (approval of application by University for research in medical use of marihuana for treatment of glaucoma; drugs to be supplied by National Institute on Drug Abuse).

III.

Plaintiff asserted his cause of action was pursuant to 19 U.S.C. § 1619

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sarlund v. United States
39 Fed. Cl. 803 (Federal Claims, 1998)
Pomeroy v. United States
39 Fed. Cl. 205 (Federal Claims, 1997)
John Doe v. United States
100 F.3d 1576 (Federal Circuit, 1996)
Nicolas v. United States
35 Fed. Cl. 387 (Federal Claims, 1996)
United States v. McMahon
673 F. Supp. 8 (D. Maine, 1987)
Rickard v. United States
11 Cl. Ct. 874 (Court of Claims, 1987)
Allen v. United States
229 Ct. Cl. 515 (Court of Claims, 1981)
Opinions of the Justices to the House of Representatives
393 N.E.2d 313 (Massachusetts Supreme Judicial Court, 1979)
Geremia v. State
573 P.2d 107 (Hawaii Supreme Court, 1977)

Cite This Page — Counsel Stack

Bluebook (online)
550 F.2d 983, 1977 U.S. App. LEXIS 14461, Counsel Stack Legal Research, https://law.counselstack.com/opinion/thomas-taylor-v-united-states-ca4-1977.